Entest BioMedical CEO to Address Shareholders on Entestbioblog.com/live - CNNMoney.com (press release)
Entest BioMedical CEO to Address Shareholders on Entestbioblog.com/live CNNMoney.com (press release) Entest BioMedical Inc. (OTCBB: ENTB) is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), ... Entest BioMedical Strengthens Its Research Capabilities by Adding Clinical ...MarketWatch (press release) Entest BioMedical Announces Creation of Proprietary Adult Stem Cell LinesPR-USA.net (press release) all 20 news articles » |
